On Tuesday, Lipella Pharmaceuticals Inc (NASDAQ: LIPO) opened higher 41.64% from the last session, before settling in for the closing price of $3.05. Price fluctuations for LIPO have ranged from $2.21 to $12.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 20.14% over the past five years. Company’s average yearly earnings per share was noted -27.44% at the time writing. With a float of $0.90 million, this company’s outstanding shares have now reached $1.09 million.
Let’s look at the performance matrix of the company that is accounted for 7 employees. In terms of profitability, gross margin is 98.75%, operating margin of -3.19%, and the pretax margin is -1058.25%.
Lipella Pharmaceuticals Inc (LIPO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Lipella Pharmaceuticals Inc is 25.35%, while institutional ownership is 5.87%. The most recent insider transaction that took place on May 14 ’24, was worth 7,590. In this transaction insider of this company bought 10,000 shares at a rate of $0.76, taking the stock ownership to the 898,849 shares. Before that another transaction happened on Mar 18 ’24, when Company’s insider below. bought 30,000 for $0.79, making the entire transaction worth $23,649. This insider now owns 863,849 shares in total.
Lipella Pharmaceuticals Inc (LIPO) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -27.44% per share during the next fiscal year.
Lipella Pharmaceuticals Inc (NASDAQ: LIPO) Trading Performance Indicators
Check out the current performance indicators for Lipella Pharmaceuticals Inc (LIPO). In the past quarter, the stock posted a quick ratio of 2.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.50 and is forecasted to reach -5.20 in one year’s time.
Technical Analysis of Lipella Pharmaceuticals Inc (LIPO)
Lipella Pharmaceuticals Inc (NASDAQ: LIPO) saw its 5-day average volume 25.94 million, a positive change from its year-to-date volume of 4.85 million. As of the previous 9 days, the stock’s Stochastic %D was 20.37%. Additionally, its Average True Range was 0.67.
During the past 100 days, Lipella Pharmaceuticals Inc’s (LIPO) raw stochastic average was set at 41.37%, which indicates a significant increase from 37.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 338.38% in the past 14 days, which was higher than the 161.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.98, while its 200-day Moving Average is $3.81. Nevertheless, the first resistance level for the watch stands at $4.74 in the near term. At $5.15, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.62. If the price goes on to break the first support level at $3.86, it is likely to go to the next support level at $3.39. Assuming the price breaks the second support level, the third support level stands at $2.98.
Lipella Pharmaceuticals Inc (NASDAQ: LIPO) Key Stats
There are currently 1,209K shares outstanding in the company with a market cap of 5.23 million. Presently, the company’s annual sales total 450 K according to its annual income of -4,620 K. Last quarter, the company’s sales amounted to 80 K and its income totaled -1,440 K.
